SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5ovn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.74A	1fk9A-5ovnA: 26.6	1fk9A-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.79A	1fk9A-5ovnA: 26.6	1fk9A-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.71A	1fk9A-5ovnB: 8.3	1fk9A-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKO_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 10	LEU A 99 VAL A 105 TYR A 180 GLY A 189 LEU A 233 TYR A 317	None	0.79A	1fkoA-5ovnA: 23.3	1fkoA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	PRO A 94 LEU A 99 TRP A 228 LEU A 233 TYR A 317	None	1.25A	1fkpA-5ovnA: 26.0	1fkpA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	PRO A 94 LEU A 99 VAL A 105 GLY A 189 TYR A 317	None	0.92A	1fkpA-5ovnA: 26.0	1fkpA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	PRO A 94 LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	1.04A	1fkpA-5ovnA: 26.0	1fkpA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IKW_A_EFZA2000_1 (POL POLYPROTEIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.78A	1ikwA-5ovnA: 26.9	1ikwA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IKW_A_EFZA2000_1 (POL POLYPROTEIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.72A	1ikwA-5ovnB: 10.4	1ikwA-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1JKH_A_EFZA999_1 (HIV-1 RT, A-CHAIN HIV-1 RT, B-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.64A	1jkhA-5ovnA: 26.5 1jkhB-5ovnA: 15.9	1jkhA-5ovnA: 55.00 1jkhB-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1JKH_A_EFZA999_1 (HIV-1 RT, A-CHAIN HIV-1 RT, B-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.71A	1jkhA-5ovnA: 26.5 1jkhB-5ovnA: 15.9	1jkhA-5ovnA: 55.00 1jkhB-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1JLF_A_NVPA999_1 (HIV-1 RT A-CHAIN HIV-1 RT B-CHAIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	LEU A 99 VAL A 105 GLY A 189 TYR A 317	None	0.82A	1jlfA-5ovnA: 25.8 1jlfB-5ovnA: 16.0	1jlfA-5ovnA: 55.00 1jlfB-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1KLM_A_SPPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 11	LEU A 99 VAL A 105 PRO A 225 LEU A 233 PRO A 235 TYR A 317	None	0.72A	1klmA-5ovnA: 25.9	1klmA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LW0_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.48A	1lw0A-5ovnB: 10.5	1lw0A-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.50A	1lwcA-5ovnB: 9.7	1lwcA-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 11	PRO A 94 LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.94A	1lwcA-5ovnA: 26.3	1lwcA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 11	PRO A 94 LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.98A	1lwcA-5ovnA: 26.3	1lwcA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWE_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	LEU A 99 VAL A 105 GLY A 189 TYR A 317	None	0.63A	1lweA-5ovnA: 26.7	1lweA-5ovnA: 56.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWE_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.37A	1lweA-5ovnB: 17.5	1lweA-5ovnB: 60.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1U_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.51A	1s1uA-5ovnB: 9.6	1s1uA-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1X_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.28A	1s1xA-5ovnB: 11.1	1s1xA-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	ASP A 109 TYR A 182 MET A 183 ASP A 184	None	1.05A	1t03A-5ovnA: 20.8	1t03A-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	ASP A 109 TYR A 182 MET A 183 ASP A 185	None	0.95A	1t03A-5ovnA: 20.8	1t03A-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	ASP B 109 MET B 183 ASP B 184 ASP B 185	None	1.31A	1t03A-5ovnB: 8.3	1t03A-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1T03_P_TFOP822_1 (POL POLYPROTEIN SYNTHETIC OLIGONUCLEOTIDE PRIMER)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 7	TYR B 182 MET B 183 ASP B 184 ASP B 185	None	1.22A	1t03A-5ovnB: 8.3	1t03A-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HND_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.75A	2hndA-5ovnA: 26.4	2hndA-5ovnA: 56.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HND_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.74A	2hndA-5ovnA: 26.4	2hndA-5ovnA: 56.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HND_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.49A	2hndA-5ovnB: 9.3	2hndA-5ovnB: 60.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.79A	2hnyA-5ovnA: 26.3	2hnyA-5ovnA: 56.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.73A	2hnyA-5ovnA: 26.3	2hnyA-5ovnA: 56.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.55A	2hnyA-5ovnB: 10.4	2hnyA-5ovnB: 60.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UXO_B_TACB1211_1 (HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LEU A 521 LEU A 428 ILE A 444 VAL A 502 ILE A 505	None	1.19A	2uxoB-5ovnA: undetectable	2uxoB-5ovnA: 17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XCT_H_CPFH1020_1 (DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	3 / 3	ARG B 376 GLU B 386 SER B 405	None	0.86A	2xctD-5ovnB: undetectable	2xctD-5ovnB: 8.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BGR_A_T27A556_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H P51 RT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LEU B 278 ASN B 280 TRP B 294 LEU B 256 GLU B 301	None	1.45A	3bgrA-5ovnB: 10.3 3bgrB-5ovnB: 11.1	3bgrA-5ovnB: 59.52 3bgrB-5ovnB: 59.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3F8F_A_DM1A127_1 (TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	ALA B 298 VAL B 302 ALA B 260 MET B 282 TRP B 294	None	1.22A	3f8fA-5ovnB: 0.7 3f8fB-5ovnB: undetectable	3f8fA-5ovnB: 24.22 3f8fB-5ovnB: 24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G1U_B_ADNB438_2 (ADENOSYLHOMOCYSTEINA SE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	3 / 3	THR A 215 GLU A 202 HIS A 197	None	0.75A	3g1uB-5ovnA: undetectable	3g1uB-5ovnA: 10.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LEU A 99 LYS A 102 TRP A 228 LEU A 233 TYR A 317	None	0.89A	3hvtA-5ovnA: 10.4	3hvtA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.84A	3hvtA-5ovnA: 10.4	3hvtA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	1.00A	3hvtA-5ovnA: 10.4	3hvtA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.89A	3hvtA-5ovnB: 9.1	3hvtA-5ovnB: 59.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 12	LEU A 99 LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.78A	3mecA-5ovnA: 26.9	3mecA-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 12	LEU A 99 VAL A 105 GLY A 189 LEU A 233 PRO A 235 TYR A 317	None	0.93A	3mecA-5ovnA: 26.9	3mecA-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.78A	3mecA-5ovnB: 10.2	3mecA-5ovnB: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEE_A_T27A561_1 (P66 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.83A	3meeA-5ovnA: 26.9	3meeA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEE_A_T27A561_1 (P66 REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PRO A 94 LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	1.00A	3meeA-5ovnA: 26.9	3meeA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 TYR A 317	None	0.75A	3qipA-5ovnA: 26.9	3qipA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.70A	3qipA-5ovnA: 26.9	3qipA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.50A	3qipA-5ovnB: 10.4	3qipA-5ovnB: 59.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 4	LYS B 216 GLN B 104 ILE B 179 LEU B 208	None	1.35A	3qt0A-5ovnB: undetectable	3qt0A-5ovnB: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S79_A_ASDA601_1 (CYTOCHROME P450 19A1)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PHE B 170 ILE B 186 THR B 106 LEU B 192 LEU B 177	None	1.24A	3s79A-5ovnB: undetectable	3s79A-5ovnB: 13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B3A_A_TACA222_1 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LEU B 288 PHE A 531 GLN B 257 VAL A 535 ILE A 503	None	1.43A	4b3aA-5ovnB: undetectable	4b3aA-5ovnB: 14.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4B3O_A_EFZA1557_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 9	LEU A 99 LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.72A	4b3oA-5ovnA: 28.3	4b3oA-5ovnA: 55.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4B3O_A_EFZA1557_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.65A	4b3oA-5ovnB: 10.1	4b3oA-5ovnB: 59.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4B3Q_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 7	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.90A	4b3qA-5ovnA: 26.5	4b3qA-5ovnA: 55.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FN9_A_STRA301_1 (STEROID RECEPTOR 2)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LEU B 253 LEU B 256 LEU B 259 ALA B 260 ALA B 277	None	0.88A	4fn9A-5ovnB: undetectable	4fn9A-5ovnB: 15.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IDK_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PRO A 94 LEU A 99 LYS A 102 VAL A 105 TYR A 317	None	1.03A	4idkA-5ovnA: 26.1	4idkA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IFY_A_T27A601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PRO A 94 LEU A 99 LYS A 102 VAL A 105 TYR A 317	None	1.04A	4ifyA-5ovnA: 26.1	4ifyA-5ovnA: 53.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KMM_B_CHDB503_0 (FERROCHELATASE, MITOCHONDRIAL)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 5	MET A 281 LEU A 278 ARG A 299 SER A 290	None	1.42A	4kmmB-5ovnA: undetectable	4kmmB-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KR4_C_AICC401_1 (OUTER MEMBRANE PROTEIN F)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	ARG B 395 TYR B 417 ASP B 75 GLU B 78	None	1.12A	4kr4C-5ovnB: undetectable	4kr4C-5ovnB: 11.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PUO_A_NVPA901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	PRO A 94 LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	1.03A	4puoA-5ovnA: 25.2	4puoA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PWD_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	0.71A	4pwdC-5ovnA: 25.0	4pwdC-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q0B_A_NVPA901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	LYS B 102 VAL B 105 TYR B 180 TYR B 187	None	0.58A	4q0bA-5ovnB: 10.1	4q0bA-5ovnB: 59.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q0B_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 9	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.77A	4q0bC-5ovnA: 25.0	4q0bC-5ovnA: 53.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.13A	4r88A-5ovnA: undetectable	4r88A-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.12A	4r88B-5ovnA: undetectable	4r88B-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.16A	4r88C-5ovnA: undetectable	4r88C-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.13A	4r88D-5ovnA: undetectable	4r88D-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.16A	4r88E-5ovnA: undetectable	4r88E-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	HIS A 197 LEU A 108 ILE A 179 GLU A 222 LEU A 220	None	1.15A	4r88F-5ovnA: undetectable	4r88F-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RYA_A_MTLA501_0 (ABC TRANSPORTER SUBSTRATE BINDING PROTEIN (SORBITOL))	5ovn	POL PROTEIN POL PROTEIN (Feline immunodeficiency virus; Feline immunodeficiency virus)	5 / 12	ARG B 142 GLY A 86 ALA A 87 ALA B 128 TRP B 56	None	1.30A	4ryaA-5ovnB: undetectable	4ryaA-5ovnB: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_F_377F402_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 8	ALA A 477 ALA A 481 ALA A 457 ALA A 454	None	0.79A	4twdF-5ovnA: undetectable 4twdG-5ovnA: undetectable 4twdH-5ovnA: undetectable 4twdI-5ovnA: undetectable 4twdJ-5ovnA: undetectable	4twdF-5ovnA: 14.38 4twdG-5ovnA: 14.38 4twdH-5ovnA: 14.38 4twdI-5ovnA: 14.38 4twdJ-5ovnA: 14.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CYM_A_T27A601_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.84A	5cymA-5ovnA: 25.9	5cymA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CYM_A_T27A601_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PRO A 94 LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	1.02A	5cymA-5ovnA: 25.9	5cymA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CYQ_A_T27A601_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 12	PRO A 94 LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.98A	5cyqA-5ovnA: 25.3	5cyqA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HBM_A_NVPA601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	LEU A 99 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.80A	5hbmA-5ovnA: 26.8	5hbmA-5ovnA: 53.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HP1_A_PPFA602_1 (HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 6	ASP A 109 GLY A 111 ASP A 112 ASP A 184	None	1.32A	5hp1A-5ovnA: 27.9	5hp1A-5ovnA: 55.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JKV_A_ASDA602_1 (AROMATASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PHE B 170 ILE B 186 THR B 106 LEU B 192 LEU B 177	None	1.24A	5jkvA-5ovnB: undetectable	5jkvA-5ovnB: 13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JSD_A_1GNA607_1 (PHIAB6 TAILSPIKE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	3 / 3	THR B 393 SER B 394 TYR B 417	None	0.85A	5jsdA-5ovnB: undetectable	5jsdA-5ovnB: 7.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JSD_C_1GNC608_1 (PHIAB6 TAILSPIKE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	3 / 3	THR B 393 SER B 394 TYR B 417	None	0.84A	5jsdC-5ovnB: undetectable	5jsdC-5ovnB: 7.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KMD_C_6UBC1304_1 (ION TRANSPORT PROTEIN)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 5	TYR B 180 ILE B 186 LEU B 91 GLY B 92	None	0.84A	5kmdC-5ovnB: undetectable 5kmdD-5ovnB: undetectable	5kmdC-5ovnB: 13.57 5kmdD-5ovnB: 13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_2 (CYCLIN-DEPENDENT KINASE 6)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	3 / 3	LYS B 327 GLN B 268 ASN B 423	None	1.02A	5l2tA-5ovnB: undetectable	5l2tA-5ovnB: 12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1803_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	ILE A 186 ILE A 188 LEU A 177 ILE A 166 ASN A 165	None	0.90A	5vkqA-5ovnA: undetectable 5vkqD-5ovnA: undetectable	5vkqA-5ovnA: undetectable 5vkqD-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_B_PCFB1808_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	ILE A 166 ASN A 165 ILE A 186 ILE A 188 LEU A 177	None	0.87A	5vkqA-5ovnA: undetectable 5vkqB-5ovnA: undetectable	5vkqA-5ovnA: undetectable 5vkqB-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1801_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	4 / 9	ILE A 166 ILE A 186 ILE A 188 LEU A 177	None	0.75A	5vkqB-5ovnA: undetectable 5vkqC-5ovnA: undetectable	5vkqB-5ovnA: undetectable 5vkqC-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_D_PCFD1801_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	ILE A 166 ASN A 165 ILE A 186 ILE A 188 LEU A 177	None	0.88A	5vkqC-5ovnA: undetectable 5vkqD-5ovnA: undetectable	5vkqC-5ovnA: undetectable 5vkqD-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9Y_A_ACTA412_0 (UNCHARACTERIZED PROTEIN KDOO)	5ovn	POL PROTEIN POL PROTEIN (Feline immunodeficiency virus; Feline immunodeficiency virus)	3 / 3	ARG A 172 PHE B 143 ARG B 141	None	1.20A	5y9yA-5ovnA: undetectable	5y9yA-5ovnA: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSG_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.80A	6bsgA-5ovnA: 25.9	6bsgA-5ovnA: 50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSG_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS B 102 VAL B 105 TYR B 180 TYR B 187 GLY B 189	None	0.93A	6bsgA-5ovnB: 10.5	6bsgA-5ovnB: 57.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSI_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	6 / 10	LEU A 99 LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.79A	6bsiA-5ovnA: 25.8	6bsiA-5ovnA: 50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSJ_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.91A	6bsjA-5ovnA: 28.8	6bsjA-5ovnA: 50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSJ_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 10	LYS A 102 VAL A 105 GLY A 189 LEU A 233 TYR A 317	None	0.89A	6bsjA-5ovnA: 28.8	6bsjA-5ovnA: 50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EF6_A_ACTA405_0 (AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	5ovn	POL PROTEIN POL PROTEIN (Feline immunodeficiency virus; Feline immunodeficiency virus)	4 / 6	THR B 364 ARG B 356 PRO A 411 ILE A 403	None	1.42A	6ef6A-5ovnB: undetectable	6ef6A-5ovnB: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6ELI_A_T27A701_1 (REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	LEU A 99 LYS A 102 VAL A 105 LEU A 233 TYR A 317	None	0.80A	6eliA-5ovnA: 25.6	6eliA-5ovnA: 48.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6ELI_A_T27A701_1 (REVERSE TRANSCRIPTASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 12	PRO A 94 LEU A 99 VAL A 105 LEU A 233 TYR A 317	None	1.03A	6eliA-5ovnA: 25.6	6eliA-5ovnA: 48.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6IEY_A_CLMA401_0 (ESTERASE)	5ovn	POL PROTEIN (Feline immunodeficiency virus)	5 / 11	ILE A 348 ALA A 97 HIS A 95 SER A 379 ALA A 326	None	1.35A	6ieyA-5ovnA: undetectable 6ieyB-5ovnA: undetectable	6ieyA-5ovnA: undetectable 6ieyB-5ovnA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JNH_A_ASCA202_0 (PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE)	5ovn	POL PROTEIN POL PROTEIN (Feline immunodeficiency virus; Feline immunodeficiency virus)	3 / 3	ASN B 135 PRO A 94 GLN A 268	None	0.86A	6jnhA-5ovnB: undetectable	6jnhA-5ovnB: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JOG_A_ASCA202_0 (PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE)	5ovn	POL PROTEIN POL PROTEIN (Feline immunodeficiency virus; Feline immunodeficiency virus)	3 / 3	ASN B 135 PRO A 94 GLN A 268	None	0.84A	6jogA-5ovnB: undetectable	6jogA-5ovnB: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.74A","1fk9A-5ovnA:26.6","1fk9A-5ovnA:55.00"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.79A","1fk9A-5ovnA:26.6","1fk9A-5ovnA:55.00"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.71A","1fk9A-5ovnB:8.3","1fk9A-5ovnB:59.76"],["1FKO_A_EFZA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;VAL A 105;TYR A 180;GLY A 189;LEU A 233;TYR A 317","None","0.79A","1fkoA-5ovnA:23.3","1fkoA-5ovnA:55.00"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;TRP A 228;LEU A 233;TYR A 317","None","1.25A","1fkpA-5ovnA:26.0","1fkpA-5ovnA:55.00"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;GLY A 189;TYR A 317","None","0.92A","1fkpA-5ovnA:26.0","1fkpA-5ovnA:55.00"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","1.04A","1fkpA-5ovnA:26.0","1fkpA-5ovnA:55.00"],["1IKW_A_EFZA2000_1","POL POLYPROTEIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.78A","1ikwA-5ovnA:26.9","1ikwA-5ovnA:55.00"],["1IKW_A_EFZA2000_1","POL POLYPROTEIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.72A","1ikwA-5ovnB:10.4","1ikwA-5ovnB:59.76"],["1JKH_A_EFZA999_1","HIV-1 RT, A-CHAIN;HIV-1 RT, B-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.64A","1jkhA-5ovnA:26.5;1jkhB-5ovnA:15.9","1jkhA-5ovnA:55.00;1jkhB-5ovnA:55.00"],["1JKH_A_EFZA999_1","HIV-1 RT, A-CHAIN;HIV-1 RT, B-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.71A","1jkhA-5ovnA:26.5;1jkhB-5ovnA:15.9","1jkhA-5ovnA:55.00;1jkhB-5ovnA:55.00"],["1JLF_A_NVPA999_1","HIV-1 RT A-CHAIN;HIV-1 RT B-CHAIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"LEU A  99;VAL A 105;GLY A 189;TYR A 317","None","0.82A","1jlfA-5ovnA:25.8;1jlfB-5ovnA:16.0","1jlfA-5ovnA:55.00;1jlfB-5ovnA:55.00"],["1KLM_A_SPPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;VAL A 105;PRO A 225;LEU A 233;PRO A 235;TYR A 317","None","0.72A","1klmA-5ovnA:25.9","1klmA-5ovnA:55.00"],["1LW0_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.48A","1lw0A-5ovnB:10.5","1lw0A-5ovnB:59.76"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.50A","1lwcA-5ovnB:9.7","1lwcA-5ovnB:59.76"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"PRO A  94;LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.94A","1lwcA-5ovnA:26.3","1lwcA-5ovnA:55.00"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"PRO A  94;LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.98A","1lwcA-5ovnA:26.3","1lwcA-5ovnA:55.00"],["1LWE_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"LEU A  99;VAL A 105;GLY A 189;TYR A 317","None","0.63A","1lweA-5ovnA:26.7","1lweA-5ovnA:56.00"],["1LWE_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.37A","1lweA-5ovnB:17.5","1lweA-5ovnB:60.98"],["1S1U_A_NVPA999_1","REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.51A","1s1uA-5ovnB:9.6","1s1uA-5ovnB:59.76"],["1S1X_A_NVPA999_1","REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.28A","1s1xA-5ovnB:11.1","1s1xA-5ovnB:59.76"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ASP A 109;TYR A 182;MET A 183;ASP A 184","None","1.05A","1t03A-5ovnA:20.8","1t03A-5ovnA:55.00"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ASP A 109;TYR A 182;MET A 183;ASP A 185","None","0.95A","1t03A-5ovnA:20.8","1t03A-5ovnA:55.00"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ASP B 109;MET B 183;ASP B 184;ASP B 185","None","1.31A","1t03A-5ovnB:8.3","1t03A-5ovnB:59.76"],["1T03_P_TFOP822_1","POL POLYPROTEIN;SYNTHETIC OLIGONUCLEOTIDE PRIMER","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"TYR B 182;MET B 183;ASP B 184;ASP B 185","None","1.22A","1t03A-5ovnB:8.3","1t03A-5ovnB:59.76"],["2HND_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.75A","2hndA-5ovnA:26.4","2hndA-5ovnA:56.70"],["2HND_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.74A","2hndA-5ovnA:26.4","2hndA-5ovnA:56.70"],["2HND_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.49A","2hndA-5ovnB:9.3","2hndA-5ovnB:60.49"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.79A","2hnyA-5ovnA:26.3","2hnyA-5ovnA:56.70"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.73A","2hnyA-5ovnA:26.3","2hnyA-5ovnA:56.70"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.55A","2hnyA-5ovnB:10.4","2hnyA-5ovnB:60.49"],["2UXO_B_TACB1211_1","HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A 521;LEU A 428;ILE A 444;VAL A 502;ILE A 505","None","1.19A","2uxoB-5ovnA:undetectable","2uxoB-5ovnA:17.06"],["2XCT_H_CPFH1020_1","DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A","5ovn","POL PROTEIN","Feline immunodeficiency virus",3,"ARG B 376;GLU B 386;SER B 405","None","0.86A","2xctD-5ovnB:undetectable","2xctD-5ovnB:8.13"],["3BGR_A_T27A556_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H;P51 RT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU B 278;ASN B 280;TRP B 294;LEU B 256;GLU B 301","None","1.45A","3bgrA-5ovnB:10.3;3bgrB-5ovnB:11.1","3bgrA-5ovnB:59.52;3bgrB-5ovnB:59.76"],["3F8F_A_DM1A127_1","TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY;TRANSCRIPTIONAL REGULATOR, PADR-LIKE FAMILY","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"ALA B 298;VAL B 302;ALA B 260;MET B 282;TRP B 294","None","1.22A","3f8fA-5ovnB:0.7;3f8fB-5ovnB:undetectable","3f8fA-5ovnB:24.22;3f8fB-5ovnB:24.22"],["3G1U_B_ADNB438_2","ADENOSYLHOMOCYSTEINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",3,"THR A 215;GLU A 202;HIS A 197","None","0.75A","3g1uB-5ovnA:undetectable","3g1uB-5ovnA:10.46"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;TRP A 228;LEU A 233;TYR A 317","None","0.89A","3hvtA-5ovnA:10.4","3hvtA-5ovnA:55.00"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.84A","3hvtA-5ovnA:10.4","3hvtA-5ovnA:55.00"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","1.00A","3hvtA-5ovnA:10.4","3hvtA-5ovnA:55.00"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.89A","3hvtA-5ovnB:9.1","3hvtA-5ovnB:59.76"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.78A","3mecA-5ovnA:26.9","3mecA-5ovnA:undetectable"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;VAL A 105;GLY A 189;LEU A 233;PRO A 235;TYR A 317","None","0.93A","3mecA-5ovnA:26.9","3mecA-5ovnA:undetectable"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.78A","3mecA-5ovnB:10.2","3mecA-5ovnB:undetectable"],["3MEE_A_T27A561_1","P66 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.83A","3meeA-5ovnA:26.9","3meeA-5ovnA:55.00"],["3MEE_A_T27A561_1","P66 REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","1.00A","3meeA-5ovnA:26.9","3meeA-5ovnA:55.00"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;TYR A 317","None","0.75A","3qipA-5ovnA:26.9","3qipA-5ovnA:55.00"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.70A","3qipA-5ovnA:26.9","3qipA-5ovnA:55.00"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.50A","3qipA-5ovnB:10.4","3qipA-5ovnB:59.76"],["3QT0_A_486A4_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"LYS B 216;GLN B 104;ILE B 179;LEU B 208","None","1.35A","3qt0A-5ovnB:undetectable","3qt0A-5ovnB:13.86"],["3S79_A_ASDA601_1","CYTOCHROME P450 19A1","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PHE B 170;ILE B 186;THR B 106;LEU B 192;LEU B 177","None","1.24A","3s79A-5ovnB:undetectable","3s79A-5ovnB:13.65"],["4B3A_A_TACA222_1","TETRACYCLINE REPRESSOR PROTEIN CLASS D","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU B 288;PHE A 531;GLN B 257;VAL A 535;ILE A 503","None","1.43A","4b3aA-5ovnB:undetectable","4b3aA-5ovnB:14.78"],["4B3O_A_EFZA1557_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.72A","4b3oA-5ovnA:28.3","4b3oA-5ovnA:55.00"],["4B3O_A_EFZA1557_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.65A","4b3oA-5ovnB:10.1","4b3oA-5ovnB:59.76"],["4B3Q_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.90A","4b3qA-5ovnA:26.5","4b3qA-5ovnA:55.00"],["4FN9_A_STRA301_1","STEROID RECEPTOR 2","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU B 253;LEU B 256;LEU B 259;ALA B 260;ALA B 277","None","0.88A","4fn9A-5ovnB:undetectable","4fn9A-5ovnB:15.55"],["4IDK_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;LYS A 102;VAL A 105;TYR A 317","None","1.03A","4idkA-5ovnA:26.1","4idkA-5ovnA:53.92"],["4IFY_A_T27A601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;LYS A 102;VAL A 105;TYR A 317","None","1.04A","4ifyA-5ovnA:26.1","4ifyA-5ovnA:53.92"],["4KMM_B_CHDB503_0","FERROCHELATASE, MITOCHONDRIAL","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"MET A 281;LEU A 278;ARG A 299;SER A 290","None","1.42A","4kmmB-5ovnA:undetectable","4kmmB-5ovnA:undetectable"],["4KR4_C_AICC401_1","OUTER MEMBRANE PROTEIN F","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ARG B 395;TYR B 417;ASP B  75;GLU B  78","None","1.12A","4kr4C-5ovnB:undetectable","4kr4C-5ovnB:11.84"],["4PUO_A_NVPA901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","1.03A","4puoA-5ovnA:25.2","4puoA-5ovnA:53.92"],["4PWD_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","0.71A","4pwdC-5ovnA:25.0","4pwdC-5ovnA:53.92"],["4Q0B_A_NVPA901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"LYS B 102;VAL B 105;TYR B 180;TYR B 187","None","0.58A","4q0bA-5ovnB:10.1","4q0bA-5ovnB:59.52"],["4Q0B_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.77A","4q0bC-5ovnA:25.0","4q0bC-5ovnA:53.92"],["4R88_A_1LDA501_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.13A","4r88A-5ovnA:undetectable","4r88A-5ovnA:undetectable"],["4R88_B_1LDB501_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.12A","4r88B-5ovnA:undetectable","4r88B-5ovnA:undetectable"],["4R88_C_1LDC501_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.16A","4r88C-5ovnA:undetectable","4r88C-5ovnA:undetectable"],["4R88_D_1LDD501_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.13A","4r88D-5ovnA:undetectable","4r88D-5ovnA:undetectable"],["4R88_E_1LDE501_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.16A","4r88E-5ovnA:undetectable","4r88E-5ovnA:undetectable"],["4R88_F_1LDF502_0","CYTOSINE DEAMINASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"HIS A 197;LEU A 108;ILE A 179;GLU A 222;LEU A 220","None","1.15A","4r88F-5ovnA:undetectable","4r88F-5ovnA:undetectable"],["4RYA_A_MTLA501_0","ABC TRANSPORTER SUBSTRATE BINDING PROTEIN (SORBITOL)","5ovn","POL PROTEIN;POL PROTEIN","Feline immunodeficiency virus;Feline immunodeficiency virus",5,"ARG B 142;GLY A  86;ALA A  87;ALA B 128;TRP B  56","None","1.30A","4ryaA-5ovnB:undetectable","4ryaA-5ovnB:undetectable"],["4TWD_F_377F402_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ALA A 477;ALA A 481;ALA A 457;ALA A 454","None","0.79A","4twdF-5ovnA:undetectable;4twdG-5ovnA:undetectable;4twdH-5ovnA:undetectable;4twdI-5ovnA:undetectable;4twdJ-5ovnA:undetectable","4twdF-5ovnA:14.38;4twdG-5ovnA:14.38;4twdH-5ovnA:14.38;4twdI-5ovnA:14.38;4twdJ-5ovnA:14.38"],["5CYM_A_T27A601_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.84A","5cymA-5ovnA:25.9","5cymA-5ovnA:53.92"],["5CYM_A_T27A601_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","1.02A","5cymA-5ovnA:25.9","5cymA-5ovnA:53.92"],["5CYQ_A_T27A601_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"PRO A  94;LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.98A","5cyqA-5ovnA:25.3","5cyqA-5ovnA:53.92"],["5HBM_A_NVPA601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.80A","5hbmA-5ovnA:26.8","5hbmA-5ovnA:53.92"],["5HP1_A_PPFA602_1","HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ASP A 109;GLY A 111;ASP A 112;ASP A 184","None","1.32A","5hp1A-5ovnA:27.9","5hp1A-5ovnA:55.00"],["5JKV_A_ASDA602_1","AROMATASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PHE B 170;ILE B 186;THR B 106;LEU B 192;LEU B 177","None","1.24A","5jkvA-5ovnB:undetectable","5jkvA-5ovnB:13.65"],["5JSD_A_1GNA607_1","PHIAB6 TAILSPIKE","5ovn","POL PROTEIN","Feline immunodeficiency virus",3,"THR B 393;SER B 394;TYR B 417","None","0.85A","5jsdA-5ovnB:undetectable","5jsdA-5ovnB:7.72"],["5JSD_C_1GNC608_1","PHIAB6 TAILSPIKE","5ovn","POL PROTEIN","Feline immunodeficiency virus",3,"THR B 393;SER B 394;TYR B 417","None","0.84A","5jsdC-5ovnB:undetectable","5jsdC-5ovnB:7.72"],["5KMD_C_6UBC1304_1","ION TRANSPORT PROTEIN;ION TRANSPORT PROTEIN","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"TYR B 180;ILE B 186;LEU B  91;GLY B  92","None","0.84A","5kmdC-5ovnB:undetectable;5kmdD-5ovnB:undetectable","5kmdC-5ovnB:13.57;5kmdD-5ovnB:13.57"],["5L2T_A_6ZZA900_2","CYCLIN-DEPENDENT KINASE 6","5ovn","POL PROTEIN","Feline immunodeficiency virus",3,"LYS B 327;GLN B 268;ASN B 423","None","1.02A","5l2tA-5ovnB:undetectable","5l2tA-5ovnB:12.68"],["5VKQ_A_PCFA1803_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"ILE A 186;ILE A 188;LEU A 177;ILE A 166;ASN A 165","None","0.90A","5vkqA-5ovnA:undetectable;5vkqD-5ovnA:undetectable","5vkqA-5ovnA:undetectable;5vkqD-5ovnA:undetectable"],["5VKQ_B_PCFB1808_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"ILE A 166;ASN A 165;ILE A 186;ILE A 188;LEU A 177","None","0.87A","5vkqA-5ovnA:undetectable;5vkqB-5ovnA:undetectable","5vkqA-5ovnA:undetectable;5vkqB-5ovnA:undetectable"],["5VKQ_C_PCFC1801_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5ovn","POL PROTEIN","Feline immunodeficiency virus",4,"ILE A 166;ILE A 186;ILE A 188;LEU A 177","None","0.75A","5vkqB-5ovnA:undetectable;5vkqC-5ovnA:undetectable","5vkqB-5ovnA:undetectable;5vkqC-5ovnA:undetectable"],["5VKQ_D_PCFD1801_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"ILE A 166;ASN A 165;ILE A 186;ILE A 188;LEU A 177","None","0.88A","5vkqC-5ovnA:undetectable;5vkqD-5ovnA:undetectable","5vkqC-5ovnA:undetectable;5vkqD-5ovnA:undetectable"],["5Y9Y_A_ACTA412_0","UNCHARACTERIZED PROTEIN KDOO","5ovn","POL PROTEIN;POL PROTEIN","Feline immunodeficiency virus;Feline immunodeficiency virus",3,"ARG A 172;PHE B 143;ARG B 141","None","1.20A","5y9yA-5ovnA:undetectable","5y9yA-5ovnA:undetectable"],["6BSG_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.80A","6bsgA-5ovnA:25.9","6bsgA-5ovnA:50.00"],["6BSG_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS B 102;VAL B 105;TYR B 180;TYR B 187;GLY B 189","None","0.93A","6bsgA-5ovnB:10.5","6bsgA-5ovnB:57.50"],["6BSI_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",6,"LEU A  99;LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.79A","6bsiA-5ovnA:25.8","6bsiA-5ovnA:50.00"],["6BSJ_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.91A","6bsjA-5ovnA:28.8","6bsjA-5ovnA:50.00"],["6BSJ_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LYS A 102;VAL A 105;GLY A 189;LEU A 233;TYR A 317","None","0.89A","6bsjA-5ovnA:28.8","6bsjA-5ovnA:50.00"],["6EF6_A_ACTA405_0","AMINOGLYCOSIDE PHOSPHOTRANSFERASE","5ovn","POL PROTEIN;POL PROTEIN","Feline immunodeficiency virus;Feline immunodeficiency virus",4,"THR B 364;ARG B 356;PRO A 411;ILE A 403","None","1.42A","6ef6A-5ovnB:undetectable","6ef6A-5ovnB:undetectable"],["6ELI_A_T27A701_1","REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"LEU A  99;LYS A 102;VAL A 105;LEU A 233;TYR A 317","None","0.80A","6eliA-5ovnA:25.6","6eliA-5ovnA:48.75"],["6ELI_A_T27A701_1","REVERSE TRANSCRIPTASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"PRO A  94;LEU A  99;VAL A 105;LEU A 233;TYR A 317","None","1.03A","6eliA-5ovnA:25.6","6eliA-5ovnA:48.75"],["6IEY_A_CLMA401_0","ESTERASE","5ovn","POL PROTEIN","Feline immunodeficiency virus",5,"ILE A 348;ALA A  97;HIS A  95;SER A 379;ALA A 326","None","1.35A","6ieyA-5ovnA:undetectable;6ieyB-5ovnA:undetectable","6ieyA-5ovnA:undetectable;6ieyB-5ovnA:undetectable"],["6JNH_A_ASCA202_0","PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE","5ovn","POL PROTEIN;POL PROTEIN","Feline immunodeficiency virus;Feline immunodeficiency virus",3,"ASN B 135;PRO A  94;GLN A 268","None","0.86A","6jnhA-5ovnB:undetectable","6jnhA-5ovnB:undetectable"],["6JOG_A_ASCA202_0","PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE","5ovn","POL PROTEIN;POL PROTEIN","Feline immunodeficiency virus;Feline immunodeficiency virus",3,"ASN B 135;PRO A  94;GLN A 268","None","0.84A","6jogA-5ovnB:undetectable","6jogA-5ovnB:undetectable"]]